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Abstract
Background: Maharishi Amrit Kalash (MAK) 5, one of the Ayurvedic food supplements, belongs
to a group of substances known as Rasayana. MAK5 and other Rasayanas are believed to enhance
the body's resistance to infections and disease, and enhance longevity. In this study, we determined
the effects of administration of MAK5, one of the Ayurvedic food supplements on immune
functions in young and old mice.
Methods: Male C3H/He N mice were divided into five groups: two no treatment groups (old
control: 22-month-old and young control: 2-month-old) and three MAK5 treated groups with
differing dose of MAK5. MAK5 was given p.o. at 50 mg/kg, 100 mg/kg or 200 mg/kg per day (3 days/
week) for 2 months.
Results: We found that glucose consumption of peritoneal macrophages from old mice treated
with MAK5 at all doses and incubated for 48 and 72 h were significantly greater than that in the
control group. Nitric oxide production of peritoneal macrophages stimulated by lipopolysaccharide
(LPS) in old mice treated with MAK5 at all doses was significantly greater than that in the old
control group, but not compared to the young control group. Stimulation index (S.I.) in old mice
gavaged with MAK5 at all doses was significantly higher than that in the old control group. IL-2
production stimulated by Con A in old mice given MAK5 at all doses was significantly higher than
that in the old control group. Production of IFN-γ stimulated by Con A in old mice given MAK5 at
doses of 100 mg/kg and 200 mg/kg were significantly higher than that in the old control group. IL-
4 production of splenic lymphocyte stimulated by Con A in old mice given MAK5 at dose levels of
100 and 200 mg/kg were significantly higher than that in the old control group.
Conclusion: The results suggest that MAK5 suppressed the age associated glucose consumption
of peritoneal macrophages and cellular immune function reduction, and that it contributes to the
prevention of the immunosenescence.
Background
It has been well documented that immune functions
declines with aging in both humans and experimental
rodents. Especially the T cell dependent functions are
compromised [1-3]. The immune functions are known to
play an important role in host defense mechanisms [4].
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Hence, it can be considered that enhancement of the
immune functions contributes to the primary prevention
of infectious illness, incidence of malignancy and autoim-
mune diseases in the elderly stage.
It is well known that dietary factors play an important role
in enhancement of health status and physically strength
in human. Epidemiological data suggest that ingestion of
some constituents from vegetables and fruits may contrib-
ute to a reduction in cancer incidence in humans [5,6]. In
experimental studies, several investigators reported that
ingestion of extracts and several components including
Ayurvedic food supplements from fruits and vegetables
suppress carcinogenesis [7-9]. In the past, foods had been
evaluated by both nutritional function (primary function)
and gustatory function (secondary function). Recently, it
has been shown that certain foods have a host defense
function related to the immune system [10-12] and anti-
oxidation [13,14] and anti-tumor [15,16] activity. The
immune system plays an important role in physical and
chemical carcinogenesis [17,18] and in tumor-bearing
hosts [19]. The role of the host immune function has
become increasingly important in our understanding of
the mechanisms that are involved in the body's ability to
prevent cancer. Although the inter-relationship between
diet, immune function and carcinogenesis is not clear,
there is increasing evidence that dietary alteration of the
host's immune functions is a key component of chemo-
prevention [20,21].
Maharishi Amrit Kalash (MAK) 5, one of the Ayurvedic
food supplements, belongs to a group of substances
known as Rasayana [22]. MAK5 is a commercially availa-
ble Rasayana that is composed of a variety of herbs, min-
erals and daily products [23]. MAK5 and other Rasayanas
are believed to enhance the body's resistance to infections
and disease, and enhance longevity [22]. Recently, few
investigators have examined the effects of several Indian
Ayurvedic products on chemically induced mammary
tumors in rats [7,23]. Vimal and his co-workers [24]
reported that ingestion of MAK4 reduces Lewis Lung Car-
cinoma (LLC) metastases in mice. Such Indian Ayurvedic
agents (MAK4 and MAK5) are also able to induce differen-
tiation of several tumor cell lines [25,26]. Although the
physiological significance of the above findings is
unknown, it might be speculated that Indian Ayurvedic
products reduces certain cancer. One of the mechanisms
by which these agents inhibit tumor metastasis and
growth could be by enhancing macrophage and lym-
phocyte functions [23,27,28]. Since Ayurvedic drugs and
food supplements contain a variety of herbs, minerals and
dairy products, the presence of such compounds is cer-
tainly possible. Hence, to our knowledge, it is very diffi-
cult to elucidate which component has the prior effect
compared to the other ingredients. In order to elucidate
the mechanism(s) of anti-cancer effects of MAK5, the
effects of MAK5 on macrophage and lymphocyte func-
tions in mice were reported in our previous studies
[11,27-29]. We found that oral administration of MAK5
enhances phagocytic activity in the reticuloendothelial
system, digestive and elimination activities of macro-
phage as primary stage of the host defense system, and
also augments proliferative responses to Con A in young
mice. However, less attention has been paid to the effects
of MAK5 on immune function, such as macrophage and
lymphocyte functions in old populations. Therefore, the
purpose of this study was to determine if MAK5 can mod-
ulate macrophage and lymphocyte functions in aged
mice. We tested this hypothesis by MAK5 treated mice for
2-month period.
In the present study, we have investigated whether gastric
intubation of MAK5 modifies (enhances) immune func-
tion, especially macrophage functions, splenic lym-
phocyte proliferation and cytokine production, in aged
mice. Macrophage function was evaluated by measuring
glucose consumption and production of NO by perito-
neal macrophages as an indicator. Mitogenic response
and production of IL-2, IFN-γ and IL-4 of spleen cells were
examined for assessment of lymphocyte function.
Materials
Chemicals
RPMI 1640 medium containing 10% heat-inactivated
fetal bovine serum (FBS), 25 mM HEPES buffer, 100
units/ml penicillin, 0.1 mg/ml streptomycin, 1 mM L-
glutamine and 0.1 M 2-mercaptoethanol was prepared by
Gibco BRL (Gibco Laboratories Life Technologies, Inc.,
New York, USA); the pH was adjusted to 7.4 with
NaHCO3. This medium was filtered sterilely with a 0.22-
µm filter (Millex-GV; Millipore, Bedford, MA). Lipopoly-
saccharide (LPS, E. coli 050: B5), concanavalin A (Con A)
and other common chemicals for the NO2
-  and
mitogenicity assay were purchased from Sigma (Sigma
Chemical Co., St. Louis, USA).
Animals
Specific pathogen-free (SPF) inbred male C3H/He N mice
were used in the present study. Young mice (2 months
old, weighing 24 to 26 g, n = 10) and old mice (22 months
old, weighing 30 to 34 g, n = 40) were obtained from
Japan SLC Inc. (Hamamatsu City, Japan). They were
housed, five per cage, with pelleted basal diet, CE-2 (CLEA
Japan, Inc., Tokyo, Japan) and water ad libitum, in an ani-
mal room under a 12 hours light-dark cycle at a tempera-
ture of 22 ± 1°C and a humidity of 60 ± 5%. After a week
acclimation, they were used for the experiment. The old
mice were divided into 4 groups. Each group consisted of
10 old mice.BMC Complementary and Alternative Medicine 2005, 5:8 http://www.biomedcentral.com/1472-6882/5/8
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Ingredients of MAK 5, and treatment
MAK5 were obtained from Maharishi Ayurveda Products
International (Lancaster, USA). The ingredients of MAK5
have been described by Sharma et al. [7]. The ingredients
in MAK5 are: gymnema aurentiacum (meda milkweed),
black musale, heart-leaved moonseed, sphaeranthus indi-
cus, butterfly pea, licorice, vanda spatulatum, elephant
creeper and indian wild pepper. The exact composition of
various ingredients in MAK 5 is not disclosed by the sup-
plier, but the quality control (e. g., minimal variation
from batch to batch) was assured.
MAK5 suspended in distilled water was given to old mice
p.o.at 50, 100 or 200 mg/kg per day (3 days/week) for 2-
month. Due to the limited number of published
researches on MAK, a standardized experimental protocol
has not been established. We assumed that every day's
MAK application would possibly cause an acute effect on
the physiological functions of the animals, leading to
death in a large number of aged mice. In order to prevent
this possibility, the animals were given MAK5 food sup-
plement every other day over the course of two months
treatment. Old control mice and young control mice were
given water as the vehicle (0.1 ml/10 g of body weight). In
order to remove the acute effects of the treatment of
MAK5, the animals were sacrificed by bleeding 24 hours
after the last administration under ether anesthesia for the
following experiments.
The experimental protocol, animal care and treatment
were approved by the Committee for Animal Studies at
Gifu University School of Medicine.
Isolation of macrophages
All procedures were conducted under aseptic conditions.
From each group 6 mice were selected for this part of
experiment. Peritoneal exudate cells (PECs) were
obtained from each mouse. Mice were sacrificed by bleed-
ing under ether anesthesia, following a method previously
described [30]. The abdomen was cleaned with 70% eth-
anol, the abdominal skin was carefully dissected without
opening the peritoneum, and 5 ml of Hanks' medium
adjusted to pH 7.4 was injected intraperitoneally. The
abdomen was massaged and 90 – 95% of the injected vol-
ume was recovered. The peritoneal resting macrophages
in the PECs suspension were isolated by the cell adhesion
method. The PECs were suspended in RPMI 1640
medium containing 10% heat-inactivated FBS and incu-
bated in a culture plate (Corning Laboratory Sciences Co.,
New York, USA) for 2 h at 37°C in a 5% CO2 incubator.
After removing non-adherent cells by washing the plate
with Hanks' medium, the adherent cells were harvested
from the bottom using a cell scraper and resuspended in
10% FBS-RPMI 1640 medium. These cells were counted,
checked for viability in trypan blue, and used in in vitro
assays for glucose consumption and production of nitric
oxide (NO2
-).
Preparation of splenic lymphocytes
All procedures were conducted under aseptic conditions.
For this part of the experiment, 4 mice were used from
each group. Mice were sacrificed by bleeding under ether
anesthesia and the single cell suspension was prepared by
pressing the spleen between two slide glasses. The cell sus-
pensions were passed through a 200-gauge stainless steel
sieve and then let to stand to remove tissue fragments.
Contaminating red blood cells were lysed by suspending
cells in 0.85% NH4 in Tris-HCl buffer. The cell suspen-
sions were centrifuged (600 × g for 10 min) and then
resuspended gently in FBS-RPMI 1640. These cells were
counted, checked for viability in trypan blue, and used in
in vitro assays for proliferative responses, production of IL-
2, IFN-γ and IL-4.
Assay of glucose consumption in peritoneal macrophages
Glucose consumption in peritoneal macrophages was
determined by the method reported previously [29].
Briefly, the supernatants (20 µl) obtained from the mac-
rophage culture sampled (1 × 105 cells/well) for 48 and 72
hours at 37°C were incubated with 3.0 ml of color reagent
for 20 min at 37°C. The optical density at 505 nm of the
solution was measured and the remaining glucose was
determined from a calibration curve with standard glu-
cose solution. The results were expressed as percent glu-
cose consumption, calculated from the following
formula:
[1 - (glucose content in culture medium cultured with
macrophages / glucose content in culture medium with-
out macrophages)] × 100.
Production of nitric oxide (NO2
-)
Macrophages (1 × 105 cells/well) were cultured at 37°C
with 5% CO2 in humidified air for 24 h with LPS (10 µg/
ml). The accumulation of NO (as measured by the metab-
olite NO2
-) in the culture supernatants was measured
using the assay system described by Ding et al. [31].
Briefly, at the end of cell culture, 100 µl of supernatant
were removed from each well onto empty the 96-well
plate. After the addition of 100 µl Griess reagent (1:1, v/v,
N-1-naphthylethylene diamine dihydrochloride 0.1% in
H2O, sulfanilamide 1% in 5% H3PO4) to each well at
room temperature for 10 min, the absorbance at 550 nm
was measured using the microplate reader (Nalge Nunc
International Co., Ltd., Immuno mino NJ-2300, Osaka,
Japan). NO2
- was determined by using sodium nitrite as a
standard (range of 0 – 100 µM). The samples were frozen
and stored at -80°C until use.BMC Complementary and Alternative Medicine 2005, 5:8 http://www.biomedcentral.com/1472-6882/5/8
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Mitogenicity assay
Assays were done in microplates (Corning Laboratory Sci-
ences Co., New York, USA) as previously described [28].
Briefly, 2 × 105 cells in 50 µl RPMI 1640 supplemented
with 10% FBS were stimulated with optimal concentra-
tion of Con A (10 µg/ml). The plates were then placed in
a 5% CO2 incubator (37°C) for 72 hours. The prolifera-
tion of spleen cells was assayed using 3-(4,5-dimethylthi-
azol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT). Six
hours before the end of the incubation, 10 µl of 0.5% MTT
dissolved in Ca2+and Mg2+ -free phosphate buffered saline
(PBS; pH 7.4) was added to the well. After the incubation,
150 µl of 0.04N HCl-isopropanol was added to each well.
Then, the optical density at 570 nm was measured by a
microtiter plate reader. The experiments were done in trip-
licate sets. The stimulation index (S. I.) was calculated
using the following equation.
S. I. = mean optical density of the cells stimulated with
Con A / mean optical density of the cells not stimulated
with Con A.
This assay method has been reported to yield results sim-
ilar to those obtained from the traditional 3H-thymidine
incorporation method [32].
Production of Interleukin-2 (IL-2), interferon-gamma (IFN-
γ) and interleukin-4 (IL-4)
The 100 µl of spleen cell suspension at a concentration of
4 × 106 cells/ml were incubated at 37°C with 5% CO2 in
humidified air for 24 hours with concanavalin A (Con A)
5 µg/ml. IL-2, IFN-γ and IL-4 activities in culture superna-
tants were determined by using the ELISA kit (Endogen,
Inc., Woburn, USA), respectively. The samples were frozen
and stored at -80°C until use. The sensitivity of IL-2, IFN-
γ and IL-4 assay were <3 pg/ml, <10 pg/ml and <5 pg/ml,
respectively.
Statistical analysis
Results were presented as the means ± SE. Data were ana-
lyzed statistically using one-way analysis of variance
(ANOVA) and post-hoc Scheffé's test for multiple compar-
isons. Significance levels were set at P <0.05.
Results
Body weight and food intake
The body weights of the old control mice were 33.6 ± 1.0
g at 22 months of age and 32.3 ± 0.9 g at 24 months of
age. The body weights of the young mice were 27.5 ± 0.2
g at 2 months of age and 29.9 ± 0.3 g at 4 months of age.
The food intake of the old control mice was 4.1 ± 0.1 g/
day/mouse. MAK5 administration scarcely affected the
body weight gain and the food intake (data not shown).
Glucose consumption capacity
The results of glucose consumption capacity in peritoneal
macrophages are shown in Figure 1. Glucose consump-
tion of peritoneal macrophages from old mice treated
with MAK5 at all doses and incubated for 48 and 72 h
were significantly greater than that in the control group (P
< 0.01 – 0.001). Glucose consumption of peritoneal mac-
rophages from young mice without treatment incubated
for 48 and 72 h were significantly greater than those in the
old mice treated with and without MAK5 (P < 0.001).
Production of NO2
-
The results of NO production (as measured by the meta-
bolic NO2
-) by peritoneal macrophages cultured for 24 h
are illustrated in Figure 2. NO2
- production of peritoneal
macrophages stimulated by LPS in old mice treated with
MAK5 at all doses was significantly greater (about two
fold) than that in the old control group (P < 0.001). NO2
-
production of peritoneal macrophages stimulated by LPS
in the young control mice without treatment was signifi-
cantly lower than that of the old mice treated with MAK5
(P < 0.001). NO2
- production of peritoneal macrophages
stimulated by LPS in the old control mice was slightly
higher than that in the young control mice; however, the
difference was not statistically significant. MAK5 at any
dose did not enhance spontaneous NO2
- production by
unstimulated peritoneal macrophages (data not shown).
Splenocytes proliferative responses
The results of Con A-stimulated splenocytes proliferative
responses are shown in Figure 3. S.I. in old mice gavaged
with MAK5 at all doses was significantly higher than that
in the control group (P < 0.01 – 0.001). S.I. in young mice
was significantly higher than those in the old mice treated
with and without MAK5 (P < 0.001). MAK5 at any dose
did not enhance spontaneous proliferation of splenic
lymphocyte without Con A stimulation in old mice (data
not shown).
Production of IL-2 and IFN-γ
The results of assays of IL-2 and IFN-γ assays are indicated
in Figures 4 and 5. When spleen cells cultured without
Con A, the production of IL-2 and IFN-γ was not detecta-
ble in the supernatant. However, cells cultured with Con
A produced significant amounts of IL-2 and IFN-γ. The
amounts of IL-2 stimulated by Con A in old mice given
MAK5 at all doses were significantly high when compared
with that in the control group (P < 0.05 – 0.001). The
amounts of IFN-γ stimulated by Con A in old mice given
MAK5 at doses of 100 mg/kg and 200 mg/kg were signifi-
cantly high when compared with that in the control group
(P < 0.05). The amounts of IL-2 and IFN-γ stimulated by
Con A in young mice without treatment were significantly
high when compared with those in the old mice treated
with and without MAK5 (P < 0.001).BMC Complementary and Alternative Medicine 2005, 5:8 http://www.biomedcentral.com/1472-6882/5/8
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IL-4 production
The data on IL-4 assay are shown in Figure 6. As in the case
of IL-2 and IFN-γ production in the spleen cells, MAK5
treatment at any dose did not enhance spontaneous IL-4
production by splenocytes in mice. The IL-4 production of
splenic lymphocyte stimulated by Con A in old mice given
MAK5 at dose levels of 50 and 200 mg/kg were signifi-
cantly high when compared with that in the control group
(P < 0.05 – 0.001). There were no significant differences
in the IL-4 production of splenic lymphocyte stimulated
by Con A between the old control mice and the young
mice without treatment.
Discussion
The results in the current study clearly indicate that oral
administration of MAK5 effectively enhances both macro-
phage and lymphocyte functions in aged mice. A recent
study suggested involvement of the immune response in
chemically induced carcinogenesis [33]. In that study, the
number of immune cells positive for dendritic cell and
macrophage common markers was significantly greater in
a  N-methyl-N'-nitro-N-nitrosoguanidine-resistant rat
strain (Buffalo) than that in a carcinogen-sensitive rat
strain (ACI). Thus, the findings in this study suggest that
immunomodulation by MAK5 may be partially responsi-
ble for inhibiting chemically induced carcinogenesis.
It is now known that the immunosuppression linked to
aging is due to a decline in the response of lymphocytes,
but not to a decline in the non-specific function of macro-
phages. Indeed, phagocyte function of macrophage could
somewhat counteract the decreased specific immune
response in old age [34].
Macrophages are known to play an important role in host
defense mechanisms for protection from microbial
Effects of Maharishi Amrit Kalash 5 (MAK5) on glucose consumption capacity of peritoneal macrophages from mice cultured  for 48–72 h Figure 1
Effects of Maharishi Amrit Kalash 5 (MAK5) on glucose consumption capacity of peritoneal macrophages from 
mice cultured for 48–72 h. Values are means ± SE. a** P < 0.01, a*** P < 0.001, with respect to old control mice; b*** P < 
0.001, with respect to young control mice.
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Effects of Maharishi Amrit Kalash 5 (MAK5) on nitric oxide (NO2
- production of peritoneal macrophages stimulated by LPS in  mice Figure 2
Effects of Maharishi Amrit Kalash 5 (MAK5) on nitric oxide (NO2
- )production of peritoneal macrophages stim-
ulated by LPS in mice. Macrophages from control (old and young) and MAK5 treated mice were incubated with LPS (10 µg/
ml) for 24 h. The accumulation of NO2
- in culture supernatants was measured by Griess reagent as described in METHOD. 
Values are means ± SE. a*** P < 0.001, with respect to old control mice; b*** P < 0.001, with respect to young control mice.
Effects of Maharishi Amrit Kalash 5 (MAK5) on the Con A stimulated splenocyte proliferative response in mice Figure 3
Effects of Maharishi Amrit Kalash 5 (MAK5) on the Con A stimulated splenocyte proliferative response in 
mice. Splenic lymphocytes from control (old and young) and MAK5 treated mice were incubated with Con A (10 µg/ml) for 
72 h. The proliferation of splenic lymphocytes was assayed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
(MTT). Values are means ± SE. a** P < 0.01, a*** P < 0.001, with respect to old control mice; b*** P < 0.001, with respect to 
young control mice.
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Effects of Maharishi Amrit Kalash 5 (MAK5) on IL-2 production of splenic lymphocytes stimulated by Con A in mice Figure 4
Effects of Maharishi Amrit Kalash 5 (MAK5) on IL-2 production of splenic lymphocytes stimulated by Con A in 
mice. Splenic lymphocytes from control (old and young) and MAK5 treated mice were incubated with Con A (5 µg/ml) for 24 
h. Production of IL-2 in culture supernatants was measured by ELISA system. Values are means ± SE. a* P < 0.05, a*** P < 
0.001, with respect to old control mice; b*** P < 0.001, with respect to young control mice.
Effects of Maharishi Amrit Kalash 5 (MAK5) on IFN-γ production of splenic lymphocytes stimulated by Con A in mice Figure 5
Effects of Maharishi Amrit Kalash 5 (MAK5) on IFN-γ production of splenic lymphocytes stimulated by Con A 
in mice. Splenic lymphocytes from control (old and young) and MAK5 treated mice were incubated with Con A (5 µg/ml) for 
24 h. Production of IFN-γ in culture supernatants was measured by ELISA system. Values are means ± SE. a* P < 0.05, a*** P < 
0.001, with respect to old control mice; b*** P < 0.001, with respect to young control mice.
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invaders [4]. Macrophage glucose consumption increases
as a result of the activation of macrophages [35]. In the
present study, glucose consumption capacity of peritoneal
macrophages from old mice treated with MAK5 at all
doses and incubated for up to 72 h was significantly
higher compared with the control group. However, glu-
cose consumption of peritoneal macrophages from young
mice without treatment incubated for 48 and 72 h were
significantly greater than those in the old mice treated
with MAK5. These results suggest that MAK5 activates
peritoneal macrophages from old mice, though it was not
as young mice. Since glucose consumption by macro-
phages is related to the pentose phosphate pathway of gly-
colysis [35], it is likely that MAK5 activates the pentose
phosphate pathway in the peritoneal macrophages.
Some researchers have suggested that NO is a cytotoxic
effector molecule of macrophage-mediated tumorcidal
actions [36,37]. Murine peritoneal macrophages in cul-
ture synthesize significant quantities of NO in response to
LPS [31,38]. Dileepan et al. [23] reported that production
of NO by LPS-activated macrophages from MAK5 treated
mice (3 months old) was significantly higher than those
from control. In the present study, we found that NO2
-
production of peritoneal macrophages stimulated by LPS
in old mice treated with MAK5 at the doses of 50, 100 and
200 mg/kg were significantly increased (about two fold)
compared with that in the old control group. Therefore, it
is speculated that the immunosuppression linked to age-
ing is not due to a decline in the non-specific function of
macrophages [34] and MAK5 ingestion enhances the
stored capacity of macrophage function even in old mice.
In this study, MAK5 treatment alone did not cause spon-
taneous elevation in NO2
- production of peritoneal mac-
rophages. These findings suggest that MAK5 treated causes
priming of macrophages for enhanced sensitivity to other
activating triggers, such as LPS and IFN-γ. Various
cytokines such as IFN-γ, interleukin-2 (IL-2), and tumor
necrosis factor-α either independently or in combination
can prime macrophages for enhanced cytolysis [39]. It has
generally been found that production of NO by macro-
phages is an important mediator of tumoricidal and
microbicidal activity [40]. Other researchers reported that
supplementation of a similar Ayurvedic herbal food sup-
plement (Maharishi Amrit Kalash 4) in experimental ani-
mals rodents resulted in decreased incidence of tumor
growth and proliferation and decrease metastases [7,24].
The mechanism(s) in which antitumor activity in made to
increase by MAK is not well documented yet. Although
previous studies [7,24] did not examine any immune
functions, the ability of MAK 5 to induce NO2
- production
from macrophages may be one of the mechanisms of can-
cer chemoprevention.
Effects of Maharishi Amrit Kalash 5 (MAK5) on IL-4 production of splenic lymphocytes stimulated by Con A in mice Figure 6
Effects of Maharishi Amrit Kalash 5 (MAK5) on IL-4 production of splenic lymphocytes stimulated by Con A in 
mice. Splenic lymphocytes from control (old and young) and MAK5 treated mice were incubated with Con A (5 µg/ml) for 24 
h. Production of IL-4 in culture supernatants was measured by ELISA system. Values are means ± SE. a* P < 0.05, a*** P < 
0.001, with respect to old control mice; b* P < 0.05, b*** P < 0.001, with respect to young control mice.
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Lectins are known to possess mitogenic activity after bind-
ing to lectin receptors [41]. T lymphocyte mitogens such
as Con A are thought to act through several subsequent
steps, initially inducing IL-1 secretion in macrophages.
Also, it is known that mitogenic activity, which reflects an
early stage in the immune response, has been measured as
a first screening of immunomodulatory activity [42]. We
[28] reported that the stimulation index of spleen cells by
Con A was increased significantly by the treatment with
MAK5 at the doses of 50, 100 and 200 mg/kg in young
mice. As shown in the present experiment, MAK5 at the
doses of 50, 100 and 200 mg/kg exerted an augmentative
effect on spleen cell proliferative responses to Con A in
old mice, though it was not as young mice.
It is accepted that cytokines are major factors involved in
the regulation of the immune response to antigens and
infectious agents. Recently, T helper cells are divided into
Th1 and Th2 cells from the profiles of cytokine secretion
[43]. It is known that Th1 cells are able to produce IL-2
and IFN-γ, whereas Th2 cells can produce IL-4 and IL-10.
Th1 cells upregulates mainly cell-mediated immunity and
downregulate humoral immunity, whereas Th2 cells act
oppositely [44]. A Th1/Th2 imbalance is found in cancer
patients [45,46]. In this study, we observed that the
amounts of IL-2 and IFN-γ, but not the amount of IL-4,
stimulated by Con A in young mice without treatment
were significantly high when compared with those in the
old mice. These results support the hypothesis that the
function of Th-1 cells declines in aged mice [47]. In the
current study, MAK5 enhanced the production of IL-2 at
doses of 50, 100 and 200 mg/kg, IFN-γ at doses of 100 and
200 mg/kg and IL-4 at doses of 50 and 200 mg/kg. We pre-
viously reported that the macrophage functions (glucose
consumption, enzyme activity) and lymphocyte prolifera-
tion in young mice (10 weeks old) is significantly higher
in groups treated with MAK at the doses of over 50 mg/kg
than in controls [28,29]. The result of the aged mice in the
present study is in good agreement with the findings of
the previous studies [28,29].
In the present study, we could not demonstrate dose-
response relationship by the applied MAK5 dosages (50,
100 and 200 mg/kg). Further research with different
MAK5 dosages should be undertaken to possibly over-
come this failure. Our results suggest that oral administra-
tion of MAK5 may affect the production of cytokines not
only from Th1 cells, such as IL-2 and IFN-γ but also from
Th2 cells, such as IL-4 in aged mice.
Conclusion
The results described here may support the hypothesis
that MAK5 directly activates macrophage activities in aged
mice, whereas it only primes lymphocytes to display a
greater immune response following interaction of splenic
lymphocytes with another stimulus, such as Con A. Our
findings suggest that MAK5 may contribute to the preven-
tion of the immunosenescence.
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